NHS approves £1.65 million sickle cell treatment with 96.6% cure rate
The National Health Service (NHS) has approved a groundbreaking £1.65 million treatment for sickle cell disease in England, offering patients ...
The National Health Service (NHS) has approved a groundbreaking £1.65 million treatment for sickle cell disease in England, offering patients ...
Nigerians living with sickle cell disease face staggering healthcare costs
U.S FDA has approved two groundbreaking gene therapies targeting sickle cell disease, marking a significant milestone in the realm of ...
A drug named Crizanlizumab, produced by Novartis has been approved for Sickle Cell treatment in England by the National Health ...